We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
For manufacturers reporting adverse incidents with intraocular lenses under the vigilance system.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Upper Tribunal Administrative Appeals Chamber decision by Mrs Justice Heather Williams, Judge Church and Judge Butler on 6 October 2025.
Phase 2 of the Airlock will include seven additional technologies spanning AI-powered clinical note taking, advanced cancer diagnostics, eye disease detection tools, and obesity treatment support systems.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Information for manufacturers of medical devices on post-market surveillance, reporting adverse incidents and field safety corrective actions to the MHRA.
Information about medical devices that the public can buy for personal use and how we make sure they are safe and effective.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).